AI assistant
Sending…
CERUS CORP — Director's Dealing 2011
May 14, 2011
33349_dirs_2011-05-13_eecbfedf-3a6e-4262-9333-836ce95fd590.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CERUS CORP (CERS)
CIK: 0001020214
Period of Report: 2011-05-11
Reporting Person: CORASH LAURENCE M (Director, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-11 | Common Stock | P | 20000 | $3.0075 | Acquired | 461700 | Direct |
| 2011-05-12 | Common Stock | P | 20000 | $2.9373 | Acquired | 481700 | Direct |
| 2011-05-13 | Common Stock | P | 20000 | $2.8722 | Acquired | 501700 | Direct |
Footnotes
F1: The price range is between $2.99 and $3.03 per share.
F2: The price range is between $2.91 and $2.94 per share.
F3: The price range is between $2.86 and $2.89 per share.
More from CERUS CORP
Interim / Quarterly Report
2026
Apr 30
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 24
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 12
Director's Dealing
2025
Nov 26